Protocol for a controlled human infection with genetically modified Neisseria lactamica expressing the meningococcal vaccine antigen NadA: a potent new technique for experimental medicine. (2019)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2018-026544

PubMed Identifier: 31048443

Publication URI: http://europepmc.org/abstract/MED/31048443

Type: Journal Article/Review

Volume: 9

Parent Publication: BMJ open

Issue: 4

ISSN: 2044-6055